Position in NBIX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$233,970
+$9,737 QoQ
Shares Held
1,776
+12.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
27,846 | $3,291,675 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
88,173 | $1,221,196 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,056 | $626,186 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,651 | $456,536 | |
| 5 | VTRS |
Viatris Inc
|
26,426 | $357,015 | |
| 6 | HLN |
Haleon plc
|
30,272 | $303,022 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
96,254 | $263,735 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,776 | $233,970 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,970 | 1,776 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $224,233 | 1,581 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $229,100 | 1,632 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $199,972 | 1,591 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $152,517 | 1,379 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $274,501 | 2,011 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $211,889 | 1,839 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $233,901 | 1,699 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $232,671 | 1,687 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $202,383 | 1,536 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $207,450 | 1,844 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $106,653 | 1,131 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $105,572 | 1,043 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $115,140 | 964 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $89,322 | 841 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $57,025 | 585 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $59,906 | 639 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $39,518 | 464 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $44,406 | 463 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $19,658 | 202 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $17,018 | 175 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $16,486 | 172 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $16,635 | 173 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $17,568 | 144 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $14,107 | 163 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||